Get the app
USHealthcare

AptarGroup Inc (ATR)

US · Healthcare · Medical Instruments & Supplies

$125.50+0.63%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$1.03B
Revenue YoY
+6.3%
Net profit
$87.6M
Profit YoY
-21.6%
EPS
$1.42
EPS estimate
$1.34
Net margin
8.5%

EPS came in at 1.42 against a street estimate of 1.34 — a beat of 6.0%.

Key statistics

Market cap
$7.82B
P/E
22.0
Forward P/E
19.3
P/B
2.95
Book value
$41.33
EPS (TTM)
$5.59
Dividend yield
1.55%
52-week high
$145.82
52-week low
$102.07
50-day MA
$131.13
200-day MA
$126.57
Beta
0.38

Analyst view

Analysts rate AptarGroup Inc a buy (5 buy, 2 hold, 0 sell out of 7) with an average price target of $170.14.

From the latest earnings call · 2026-07-31

MIXED Q2 beat EPS guidance driven by Pharma strength offsetting emergency medicine destocking and Beauty/Closures operational drag. CEO transition complete; new leader signals operational focus and margin recovery ahead. Q2 2026 Americas remains pressure point for Beauty; Brazil customer-driven destocking offset by Asia/Europe strength and robust Pharma global demand. Analysts pressed on Beauty turnaround timing and structural fixes; Touya pledged fresh operational focus and customer-centric reallocation but avoided commitments. Pharma long-term 7–11% growth reaffirmed; 2026 below-trend largely due to EM destocking, not loss of underlying momentum. 2026-07-31…

Full summary in the app.

Shareholding

Insiders
0.86%
Institutions
99.06%

Largest institutional holders

FundStake
BlackRock Inc9.57%
State Farm Mutual Automobile Ins Co7.46%
Vanguard Portfolio Management, LLC5.93%
Morgan Stanley - Brokerage Accounts5.31%
Vanguard Capital Management, LLC4.54%
State Street Corp4.38%
Victory Capital Management Inc.4.02%
Dimensional Fund Advisors, Inc.2.74%

Recent filings & reports

DocumentDate
Board / officer change · Q3 2026
APTARGROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial numbers disclosed - This is a personnel/governance filing, not an earnings repor
2026-09-10
Board / officer change · Q3 2026
APTARGROUP, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Board size increased from 10 to 11 directors on August 29, 2026 • New director appointment ef
2026-09-01
Quarterly report · Q2 2026
APTARGROUP, INC. - FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Net Sales (6 months): $2,009,376 thousand, up 8.4% vs. $1,8
2026-07-31
Results announced · Q3 2026
APTAR GROUP, INC. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Sales: $1.03 billion, up 6% reported / up 1% core sales (excluding currency
2026-07-30
Board / officer change · Q2 2026
APTARGROUP, INC. - FORM 8-K SUMMARY Filing Date: May 10, 2026 --- HEADLINE NUMBERS • Sign-on bonus for new Chief Accounting Officer: $105,000 (paya
2026-05-13
Shareholder vote results · Q2 2026
APTARGROUP, INC. - FORM 8-K SUMMARY (MAY 6, 2026) HEADLINE NUMBERS • Annual Stockholder Meeting held: May 6, 2026 • Total votes cast (approximate):
2026-05-07
Quarterly report · Q1 2026
APTARGROUP, INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Sales: $982.9 million (Q1 2026) vs $887.3 million (Q1 2025) — increase of $95.6 milli
2026-05-01
Proxy statement · Q2 2026
APTARGROUP, INC. PROXY STATEMENT SUMMARY CEO COMPENSATION • Current CEO (Stephan B. Tanda): Total 2025 compensation not specified in provided excerp
2026-03-27

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.48 / share
ex-date Jul 30, 2026 · pay Aug 20, 2026
2026-07-30
Dividend$0.48 / share
ex-date May 6, 2026 · pay May 27, 2026
2026-05-06
Dividend$0.48 / share
ex-date Feb 4, 2026 · pay Feb 25, 2026
2026-02-04
Dividend$0.48 / share
ex-date Oct 23, 2025 · pay Nov 13, 2025
2025-10-23

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for AptarGroup Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.